|Day Low/High||115.68 / 121.53|
|52 Wk Low/High||90.14 / 196.00|
GW Pharma's drug showed impressive results for treating schizophrenia, Cramer says. Investors looking to buy high-quality consumer companies like Kimberly-Clark should wait for the Fed's rate decision.
Rite Aid and GW Pharmaceuticals both have positive catalysts — and bullish analyst coverage — to help push their share prices higher, Cramer says.
- FDA Orphan Designation Previously Granted -
Cramer says we're too late on NutriSystem while AmerisourceBergen is a terrific buy.
China's problems continue to knock a number of U.S. stocks upside the head, Cramer says.
Cramer is sticking with Domino's in the pizza wars and he likes Bed Bath the store but not the stock.
Health care stocks rose after the High Court's ruling but don't expect magic for everyone until there's a Greek deal.
Want to invest in marijuana stocks? You'd better do your homework first -- otherwise, you might get burned.
Answering a viewer's Twitter question, Jim Cramer says market will dip for several weeks after the Federal Reserve raises rates.
Jim Cramer answers viewers' Twitter (TWTR) questions from the floor of the New York Stock Exchange.
U.S. Operations to be Located in Southern California
Conference Call Today at 8:00 a.m. EDT, 1:00 p.m. BST
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.